177Lu-IPN01072

· Ariceum Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-IPN01072, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 [NA]